# Question 12

**Type:** Out of scope

**Question:** For patients with the EML4-ALK fusion gene in lung cancer how do the different fusion variants affect their long-term quality of life and risk of developing a secondary cancer?

**Answer:**

Based on my comprehensive analysis of the cBioPortal database, I can provide you with information about EML4-ALK fusions in lung cancer patients and the available data, though there are some important limitations regarding quality of life and secondary cancer outcomes.

## Summary of EML4-ALK Fusion Data in Lung Cancer

I found **334 unique patients** with EML4-ALK fusions across multiple lung cancer studies in the database. The fusion variants identified include:

### Different EML4-ALK Fusion Variants:
1. **In-frame fusions** (most common):
   - "Protein fusion: in frame (EML4-ALK)" - 199 cases
   - "Protein Fusion: in frame {EML4:ALK}" - 180 cases
   - Various other in-frame notations

2. **Mid-exon fusions**:
   - "Protein Fusion: mid-exon {EML4:ALK}" - 24 cases
   - "Protein fusion: mid-exon (EML4-ALK)" - 14 cases

3. **Out-of-frame fusions** (rare):
   - "Protein fusion: out of frame (EML4-ALK)" - 6 cases
   - "Protein Fusion: out of frame {EML4:ALK}" - 4 cases

### Available Clinical Outcome Data:
The database contains survival data for these patients:
- **Overall survival (OS)**: 298 patients have OS_STATUS and OS_MONTHS data
- **Progression-free survival (PFS)**: 9 patients have PFS_MONTHS data
- **Disease-free survival (DFS)**: 2 patients have DFS data
- **Metastasis timing**: 87 patients have data on time to various metastatic sites (brain, liver, lung, bone, etc.)

## Limitations Regarding Your Specific Questions:

**Quality of Life Data**: Unfortunately, the cBioPortal database does not contain standardized quality of life measurements or patient-reported outcome data for these patients. The available clinical attributes focus primarily on molecular characteristics, treatment responses, and survival endpoints.

**Secondary Cancer Data**: The database does not contain specific information about secondary cancers or subsequent malignancies in these patients. The clinical timeline events include treatment, diagnosis, and disease progression events, but not secondary cancer diagnoses.

## Clinical Insights from Available Data:

While I cannot provide the specific quality of life and secondary cancer outcomes you requested, the data shows that:

1. **Fusion Variant Distribution**: The majority of EML4-ALK fusions are in-frame variants, which typically preserve protein function and are associated with better treatment responses to ALK inhibitors.

2. **Survival Data Available**: There is substantial survival data (298 patients with OS data) that could potentially be analyzed by fusion variant type to understand long-term outcomes.

3. **Metastasis Patterns**: Data on time to various metastatic sites is available for 87 patients, which could provide insights into disease progression patterns by fusion variant.

To fully answer your research question about quality of life and secondary cancer risk by fusion variant, you would likely need to access:
- Patient-reported outcome databases
- Cancer registry data with long-term follow-up
- Specialized cohort studies focusing on ALK-positive lung cancer patients

The current cBioPortal database provides excellent genomic and basic clinical outcome data but lacks the patient-reported outcomes and long-term surveillance data needed to address quality of life and secondary cancer questions comprehensively.

---

## SQL Queries Executed

### Query 1
**Timestamp:** 2025-09-30 17:49:37

```sql
SELECT cancer_study_identifier, name, description
FROM cancer_study
WHERE (name LIKE '%lung%' OR description LIKE '%lung%' OR name LIKE '%NSCLC%' OR description LIKE '%NSCLC%')
LIMIT 10
```

### Query 2
**Timestamp:** 2025-09-30 17:49:43

```sql
SELECT
cs.cancer_study_identifier,
cs.name AS study_name,
gv.sample_unique_id,
gv.patient_unique_id,
gv.hugo_gene_symbol,
gv.sv_event_info
FROM genomic_event_derived gv
JOIN cancer_study cs ON gv.cancer_study_identifier = cs.cancer_study_identifier
WHERE gv.variant_type = 'structural_variant'
AND (gv.hugo_gene_symbol IN ('EML4', 'ALK') OR gv.sv_event_info LIKE '%EML4%' OR gv.sv_event_info LIKE '%ALK%')
AND (cs.name LIKE '%lung%' OR cs.name LIKE '%NSCLC%' OR cs.description LIKE '%lung%' OR cs.description LIKE '%NSCLC%')
LIMIT 20
```

### Query 3
**Timestamp:** 2025-09-30 17:49:48

```sql
SELECT
cs.cancer_study_identifier,
cs.name AS study_name,
gv.sample_unique_id,
gv.patient_unique_id,
gv.hugo_gene_symbol,
gv.sv_event_info
FROM genomic_event_derived gv
JOIN cancer_study cs ON gv.cancer_study_identifier = cs.cancer_study_identifier
WHERE gv.variant_type = 'structural_variant'
AND (gv.sv_event_info LIKE '%EML4%ALK%' OR gv.sv_event_info LIKE '%ALK%EML4%')
AND (cs.name LIKE '%lung%' OR cs.name LIKE '%NSCLC%' OR cs.description LIKE '%lung%' OR cs.description LIKE '%NSCLC%')
ORDER BY gv.patient_unique_id
```

### Query 4
**Timestamp:** 2025-09-30 17:49:57

```sql
SELECT COUNT(DISTINCT patient_unique_id) as unique_patients
FROM genomic_event_derived gv
JOIN cancer_study cs ON gv.cancer_study_identifier = cs.cancer_study_identifier
WHERE gv.variant_type = 'structural_variant'
AND (gv.sv_event_info LIKE '%EML4%ALK%' OR gv.sv_event_info LIKE '%ALK%EML4%')
AND (cs.name LIKE '%lung%' OR cs.name LIKE '%NSCLC%' OR cs.description LIKE '%lung%' OR cs.description LIKE '%NSCLC%')
```

### Query 5
**Timestamp:** 2025-09-30 17:50:05

```sql
SELECT DISTINCT attribute_id, display_name, description
FROM clinical_attribute_meta
WHERE (display_name LIKE '%quality%' OR display_name LIKE '%QoL%' OR display_name LIKE '%life%' OR
display_name LIKE '%secondary%' OR display_name LIKE '%second%' OR description LIKE '%quality%' OR
description LIKE '%secondary%' OR display_name LIKE '%subsequent%')
AND cancer_study_identifier IN (
SELECT DISTINCT cs.cancer_study_identifier
FROM cancer_study cs
WHERE (cs.name LIKE '%lung%' OR cs.name LIKE '%NSCLC%' OR cs.description LIKE '%lung%' OR cs.description LIKE '%NSCLC%')
)
LIMIT 20
```

### Query 6
**Timestamp:** 2025-09-30 17:50:16

```sql
SELECT DISTINCT attr_id, display_name, description
FROM clinical_attribute_meta
WHERE (display_name LIKE '%quality%' OR display_name LIKE '%QoL%' OR display_name LIKE '%life%' OR
display_name LIKE '%secondary%' OR display_name LIKE '%second%' OR description LIKE '%quality%' OR
description LIKE '%secondary%' OR display_name LIKE '%subsequent%')
LIMIT 20
```

### Query 7
**Timestamp:** 2025-09-30 17:50:23

```sql
SELECT DISTINCT attr_id, display_name, description
FROM clinical_attribute_meta
WHERE (display_name LIKE '%survival%' OR display_name LIKE '%follow%' OR display_name LIKE '%outcome%' OR
display_name LIKE '%death%' OR display_name LIKE '%status%' OR display_name LIKE '%event%' OR
display_name LIKE '%time%' OR description LIKE '%survival%' OR description LIKE '%follow%' OR
display_name LIKE '%malign%' OR display_name LIKE '%cancer%' OR display_name LIKE '%tumor%')
LIMIT 30
```

### Query 8
**Timestamp:** 2025-09-30 17:50:29

```sql
SELECT DISTINCT sv_event_info, COUNT(*) as count
FROM genomic_event_derived gv
JOIN cancer_study cs ON gv.cancer_study_identifier = cs.cancer_study_identifier
WHERE gv.variant_type = 'structural_variant'
AND (gv.sv_event_info LIKE '%EML4%ALK%' OR gv.sv_event_info LIKE '%ALK%EML4%')
AND (cs.name LIKE '%lung%' OR cs.name LIKE '%NSCLC%' OR cs.description LIKE '%lung%' OR cs.description LIKE '%NSCLC%')
GROUP BY sv_event_info
ORDER BY count DESC
```

### Query 9
**Timestamp:** 2025-09-30 17:50:38

```sql
SELECT DISTINCT event_type
FROM clinical_event_derived
WHERE patient_unique_id IN (
SELECT DISTINCT patient_unique_id
FROM genomic_event_derived gv
JOIN cancer_study cs ON gv.cancer_study_identifier = cs.cancer_study_identifier
WHERE gv.variant_type = 'structural_variant'
AND (gv.sv_event_info LIKE '%EML4%ALK%' OR gv.sv_event_info LIKE '%ALK%EML4%')
AND (cs.name LIKE '%lung%' OR cs.name LIKE '%NSCLC%' OR cs.description LIKE '%lung%' OR cs.description LIKE '%NSCLC%')
)
LIMIT 20
```

### Query 10
**Timestamp:** 2025-09-30 17:50:48

```sql
SELECT DISTINCT attribute_name, COUNT(*) as patient_count
FROM clinical_data_derived
WHERE patient_unique_id IN (
SELECT DISTINCT patient_unique_id
FROM genomic_event_derived gv
JOIN cancer_study cs ON gv.cancer_study_identifier = cs.cancer_study_identifier
WHERE gv.variant_type = 'structural_variant'
AND (gv.sv_event_info LIKE '%EML4%ALK%' OR gv.sv_event_info LIKE '%ALK%EML4%')
AND (cs.name LIKE '%lung%' OR cs.name LIKE '%NSCLC%' OR cs.description LIKE '%lung%' OR cs.description LIKE '%NSCLC%')
)
AND (attribute_name LIKE '%survival%' OR attribute_name LIKE '%follow%' OR attribute_name LIKE '%death%' OR
attribute_name LIKE '%status%' OR attribute_name LIKE '%outcome%' OR attribute_name LIKE '%time%' OR
attribute_name LIKE '%DFS%' OR attribute_name LIKE '%OS%' OR attribute_name LIKE '%DAYS%' OR
attribute_name LIKE '%MONTHS%')
GROUP BY attribute_name
ORDER BY patient_count DESC
```


---

## Model Information
**Model:** anthropic:claude-sonnet-4-20250514
**Provider:** Anthropic
**Max Tokens:** 4096

---

*Generated on 2025-09-30 17:51:08*